Cytokinetics Stock Forecast
About Chart
Golden Star
The Golden Star is a refined bullish signal based on the Golden Cross, developed by Jim Stromberg, incorporating additional time frame-specific moving averages and precise price line crossings. This signal is effective for liquid stocks, highlighting short-term upward momentum.
Death Star
The Death Star, developed by Jim Stromberg, is the bearish counterpart to the Golden Star, serving as a sell signal. It is triggered by specific moving average crossings on the price line, indicating a likely prolonged decline in the stock.
Golden Cross
The Golden Cross is a bullish signal where the short-term moving average crosses above the long-term moving average, indicating potential upward momentum.
Death Cross
The Death Cross is a bearish signal where the short-term moving average crosses below the long-term moving average, indicating potential downward momentum.
Pivot Bottom
A Pivot Bottom is a significant low point identified by algorithms developed by StockInvest.us. While it may indicate a short-term directional change, it does not necessarily imply a complete trend reversal. Pivot Bottoms are marked as green circles on the price line.
Pivot Top
A Pivot Top represents a significant high point identified by algorithms developed by StockInvest.us. Similar to Pivot Bottoms, it may suggest a short-term directional change within the main trend, rather than a full trend reversal. Pivot Tops are marked as red circles on the price line.
RSI Oversold
RSI oversold indicates that a stock has declined significantly and may be undervalued, potentially presenting a buying opportunity. This condition is marked by a green line on the chart but should be confirmed with other indicators before taking action.
RSI Overbought
RSI overbought suggests that a stock has risen rapidly and may be due for a pullback. It is marked by a red line on the chart, signaling increased risk. This doesn’t necessarily mean it’s time to sell, but it’s important to monitor closely.
Accumulated Volume
The bars indicate how much stock has been traded on each price during the chart period.
Buy Signal (MA)
Buy signal from moving average indicating potential upward movement.
Sell Signal (MA)
Sell signal from moving average indicating potential downward movement.
Stock Analysis |
|
Risk Assessment |
|
Trading Strategy |
|
Cytokinetics stock price up 1.61% on Friday
(Updated on Nov 01, 2024)
Sell candidate since Oct 23, 2024
Loss -2.30%
The Cytokinetics stock price gained 1.61% on the last trading day (Friday, 1st Nov 2024), rising from $51.00 to $51.82. During the last trading day the stock fluctuated 2.53% from a day low at $51.07 to a day high of $52.36. The price has fallen in 7 of the last 10 days and is down by -5.73% for this period. Volume fell on the last day by -106 thousand shares and in total, 858 thousand shares were bought and sold for approximately $44.45 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.65% during the next 3 months and, with a 90% probability hold a price between $45.33 and $52.50 at the end of this 3-month period.
CYTK Signals & Forecast
There are mixed signals in the stock today. The Cytokinetics stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $53.75. On a fall, the stock will find some support from the short-term average at $51.66. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Thursday, October 31, 2024, and so far it has risen 1.61%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.
Support, Risk & Stop-loss for Cytokinetics stock
Cytokinetics finds support from accumulated volume at $51.32 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.29 between high and low, or 2.53%. For the last week, the stock has had daily average volatility of 2.20%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CYTK) For The Upcoming Trading Day Of Monday 4th
For the upcoming trading day on Monday, 4th we expect Cytokinetics to open at $51.75, and during the day (based on 14 day Average True Range), to move between $50.16 and $53.48, which gives a possible trading interval of +/-$1.66 (+/-3.21%) up or down from last closing price. If Cytokinetics takes out the full calculated possible swing range there will be an estimated 6.42% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $51.32 (0.96%) than the resistance at $53.77 (3.76%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Cytokinetics will release earnings AMC on Wednesday, November 06, 2024.The consensus among the analysts for the expected earnings (EPS) is -$1.25. We will update the financials statements for Cytokinetics, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 6.07% in the first trading day after earnings release.
Is Cytokinetics stock A Buy?
Cytokinetics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -1.381 Sell Candidate Unchanged
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
Predicted Fair Opening Price
Predicted fair opening price on November 4, 2024 - $51.75 ( 0.135%).Trading levels for CYTK
Fibonacci Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 53.04 | 2.35% |
R2 | 52.55 | 1.40% |
R1 | 52.24 | 0.82% |
Price | 51.82 | |
S1 | 51.26 | -1.09% |
S2 | 50.95 | -1.67% |
S3 | 50.46 | -2.62% |
Accumulated Volume Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 56.16 | 8.38% |
R2 | 55.60 | 7.29% |
R1 | 53.77 | 3.76% |
Price | 51.82 | |
S1 | 51.32 | -0.96% |
S2 | 51.22 | -1.16% |
S3 | 51.00 | -1.58% |
FAQ
Click here for our free guide on how to buy Cytokinetics Stock.